← Leaderboards
Gary S Wood
Case Western Reserve University
$1,920,005
Attributed
$1,920,005
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,493,740 · 8
VA$0 · 1
By mechanism
P30$3,659,163 · 3
K24$453,556 · 1
R21$366,053 · 1
M01$14,968 · 3
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Amitabh Chak$17,077,792
- Kishore Guda$5,264,331
- Sanford D Markowitz$49,710,196
- Kevin D Cooper$16,666,288
- Elma D Baron$2,530,774
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchMycosis Fungoides LymphomaProgramsCutaneousCell DeathBaseSkin DisorderRegulationInnovationBiopsyPublic Health RelevanceExhibitsGene ExpressionEpigenetic ProcessDna MethylationMessenger RnaMethotrexateCollaborationsApoptoticDemethylationIn VitroCessation Of LifeDesignApoptosis
Grant awards (25)
Skin Diseases Research Center at the University of Wisconsin$514,747
P30 · FY2018 · AR · contact PI
Administrative core$397,200
P30 · FY2018 · AR · contact PI
FAS Pathway Abnormalities in MF and SS$0
I01 · FY2018 · VA · contact PI
Skin Diseases Research Center at the University of Wisconsin$349,593
P30 · FY2017 · AR · contact PI
Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL)$166,388
R21 · FY2017 · CA · contact PI
FAS Pathway Abnormalities in MF and SS$0
I01 · FY2017 · VA · contact PI
Skin Diseases Research Center at the University of Wisconsin$514,747
P30 · FY2016 · AR · contact PI
Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL)$199,665
R21 · FY2016 · CA · contact PI
FAS Pathway Abnormalities in MF and SS$0
I01 · FY2016 · VA · contact PI
Skin Diseases Research Center at the University of Wisconsin$679,901
P30 · FY2015 · AR · contact PI
Analytics and Synthesis Core (p 235-279)$344,114
P30 · FY2015 · AR · contact PI
FAS Pathway Abnormalities in MF and SS$0
I01 · FY2015 · VA · contact PI
Skin Diseases Research Center at the University of Wisconsin$514,747
P30 · FY2014 · AR · contact PI
Analytics and Synthesis Core (p 235-279)$344,114
P30 · FY2014 · AR · contact PI
PHASE II RHIL-12 IN MF WITH CROSS-OVER TO PHASE I IL-2 ADMINISTERED WITH IL-12$310
M01 · FY2006 · RR · contact PI
PHASE II RHIL-12 IN MF WITH CROSS-OVER TO PHASE I IL-2 ADMINISTERED WITH IL-12$5,992
M01 · FY2005 · RR
Phase II rhIL-12 in MF with Cross-over to Phase I IL-2 Administered with IL-12$8,666
M01 · FY2004 · RR
TRANSLATIONAL RESEARCH &MENTORING IN CUTANEOUS LYMPHOMA$114,691
K24 · FY2003 · AR
TRANSLATIONAL RESEARCH &MENTORING IN CUTANEOUS LYMPHOMA$113,806
K24 · FY2002 · AR
Phase I trial of 06 benzylguanine &BCNU in cutaneous t cell lymphoma$0
M01 · FY2002 · RR
TRANSLATIONAL RESEARCH &MENTORING IN CUTANEOUS LYMPHOMA$112,946
K24 · FY2001 · AR
Phase I trial of 06 benzylguanine &BCNU in cutaneous t cell lymphoma$0
M01 · FY2001 · RR
TRANSLATIONAL RESEARCH &MENTORING IN CUTANEOUS LYMPHOMA$63,853
K24 · FY2000 · AR
TRANSLATIONAL RESEARCH &MENTORING IN CUTANEOUS LYMPHOMA$48,260
K24 · FY2000 · AR
Phase I trial of 06 benzylguanine &BCNU in cutaneous t cell lymphoma$0
M01 · FY2000 · RR